Skip to main content
. 2021 Jan 14;10:27. doi: 10.1186/s13643-020-01562-9

Table 1.

Eligibility criteria

Population Adults (aged ≥ 18 years) with type 1 or type 2 diabetes in LMICs who have been identified as needing treatment for DR and/or DMO
Intervention Any intervention that seeks to increase uptake and/or completion of treatment for DR and/or DMO among adults with diabetes
Comparator Usual care or another intervention seeking to increase uptake and/or completion of treatment for DR and/or DMO
Outcomes

1. Proportion of patients initiating treatment for DR and/or DMO among those to whom it is recommended

2. Proportion of patients completing treatment for DR and/or DMO among those to whom it is recommended

3. Proportion of patients completing treatment for DR and/or DMO among those initiating treatment

4. Number and proportion of DR and/or DMO rounds of treatment completed per patient, as dictated by the treatment protocol

5. Cost-effectiveness of intervention to increase DR/DMO treatment uptake or completion

Study design Any interventional or observational comparative study